Centanafadine is a “new” drug currently in phase 3 clinical trials as a treatment for adhd in the form of a sustained release tablet to be taken 2 times a day. It is a triple reuptake inhibitor of norepinephrine, dopamine, and serotonin in that order. You can find more information with the...
